CO-CHAIRS

Charles K. Sholtz

Director and Associate General Counsel
Biosimilars, Manufacturing & Litigation Readiness Lead
Genentech (South San Francisco, CA)

Co-Chair’s Opening Remarks

June 24, 2019 8:00 am

Immac “Casey” Thampoe

Executive Director/Assistant General Counsel, IP Portfolio Development
Regeneron Pharmaceuticals, Inc. (Tarrytown, NY)

Co-Chair’s Opening Remarks

June 24, 2019 8:00 am

SPEAKERS

Jeffrey C. Bank

Partner
Wilson Sonsini Goodrich & Rosati (New York, NY)

Dr. David Blackburn

Managing Director and Head of NERA’s Life Sciences Industry Group
NERA Economic Consulting

The Honorable Jacqueline Bonilla

Deputy Chief Judge
Patent Trial and Appeal Board
U.S. Patent & Trademark Office

View from the Bench

June 25, 2019 9:45 am

Maureen Bresnahan

Assistant General Counsel
Eisai (Andover, MA)

Jonathan S. Caplan

Partner
Kramer Levin Naftalis & Frankel LLP

View from the Bench

June 25, 2019 9:45 am

David W. Clough

Senior Partner
Polsinelli PC (Chicago, IL)

Carol Pitzel Cruz

Partner
Knobbe Martens (Seattle, WA)

Jeffrey K. Francer

Senior Vice President & General Counsel
Association for Accessible Medicines (AAM) (Washington, DC)

Joseph Franklin

Associate Director for Policy, Therapeutic Biologics and Biosimilars Staff Office of New Drugs, CDER
U.S. Food & Drug Administration (Washington, DC)

Nicholas Groombridge

Partner
Paul, Weiss, Rifkind, Wharton & Garrison LLP (New York, NY)

Jonathan A. Harris

Partner
Axinn Veltrop & Harkrider LLP (Hartford, CT)

Omar Jabri

Senior Director of Global Intellectual Property
Apotex Inc. (Toronto, CA)

Michael W. Johnson

Partner
Willkie Farr & Gallagher LLP (New York, NY)

David Korn

Vice President, Intellectual Property and Law
PhRMA (Washington, DC)

Steven D. Maslowski

Partner
Akin Gump Strauss Hauer & Feld LLP (Philadelphia, PA)

Brian McCormick

Vice President & Chief Regulatory Counsel
Teva Pharmaceuitcals (Horsham, PA)

Dr. Christine Meyer

Managing Director and Chair of NERA’s Global Intellectual Property Practice
NERA Economic Consulting

John J. Molenda

Partner
Steptoe & Johnson LLP (New York, NY)

Jason Murata

Partner
Axinn, Veltrop & Harkrider LLP (San Francisco, CA)

Matthew A. Pearson

Partner
Akin Gump Strauss Hauer & Feld LLP (Philadelphia, PA)

Julia Pike

Vice President of Intellectual Property, North America
Sandoz (Princeton, NJ)

Kevin S. Prussia

Partner
Wilmer Cutler Pickering Hale and Dorr LLP (Boston, MA)

Colman Ragan

VP & General Counsel
North America IP
Teva Pharmaceuticals

Tara Rahemba

Senior Director, Patent Counsel
Alexion Pharmaceuticals, Inc. (New Haven, CT)

Honorable Teresa Rea

Partner
Crowell & Moring LLP (Washington, DC) (Former Acting Under Secretary of Commerce for Intellectual Property and Former Acting Director of the United States Patent and Trademark Office)

Hans Sauer

Deputy General Counsel, VP for Intellectual Property
Biotechnology Innovation Organization (Washington, DC)

Petra Scamborova

Director, Dispute Resolution
Regeneron Pharmaceuticals, Inc.

Timothy Shea Jr.

Director
Sterne Kessler Goldstein & Fox, P.L.L.C. (Washington, DC)
Laura Sim

Laura Sim

Sr. Counsel
Development, Regulatory, Operations & Contracting Law
Amgen

Laura Storto

Assistant General Counsel, Associate Director
Genentech (South San Francisco, CA)

Jeanna M. Wacker

Partner
Kirkland & Ellis LLP(New York, NY)

Mark E. Waddell

Co-Chair, Life Sciences
Loeb & Loeb LLP (New York, NY)

Elizabeth S. Weiswasser

Partner
Weil, Gotshal & Manges LLP (New York, NY)

Lori Wolfe

Assoc. General Counsel, North America IP Litigation
Teva Pharmaceuticals

Timothy Worrall

Shareholder
Polsinelli PC (Denver, CO)